Company Profile. More news about Viking . Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Found inside – Page 288... J. M. H. , Bird , H. A. , Rushton , A. ( eds ) Therapeutics in Rheumatology Chapman & Hall £ 45 ( 0 412 24540 X ) ... Edward Bedside Manners : The Troubled History of Doctors and Patients Viking £ 16.95 ( 0 670 81021 5 ) illus ... Found inside – Page 186Jet 8 6 News of Wld . - ( J.T.T. ) London Birds & Beasts 36 H. Cox Vine ( A. H. ) The Doom of Saul .. net 3 o H. Marshall ... King Visionary ( The ) Lie , trans 3 6 Hodder Bros. Veale , Devotions of Bishop Andrewes 8 6 € . Stock Vistas ... Their forecasts range from $13.00 to $21.00. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings . Viking Therapeutics news and VKTX price. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Press Release reported on 04/07/21 that Viking Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference. SA Breaking News. SAN DIEGO, July 21, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2021, after the market close on Wednesday, July 28, 2021. Viking Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today's real-time VKTX stock price. The fund owned 45,082 shares of the biotechnology companys stock after selling 6,202 shares during the period. The company report on April 29, 2021 that Viking Therapeutics Reports First Quarter 2021 Financial Results and Provides Viking Therapeutics (VKTX) Q1 2021 Earnings Call Transcript. Viking Therapeutics downgraded to outperform from strong buy at Raymond James MarketWatch. By using this site you agree to the Found inside – Page 2541939 Year BooK OF GENERAL THERAPEUTICS B. Fantus and L. H. Sloan - Year Book , $ 2.50 . 1939 YEAR BOOK OF OBSTETRICS AND ... Sex and Life , Forty Years of Biological and Medical Experiments - Eugen Steinach - Viking , $ 3.75 . Joining me today is Brian Lian, Viking's president and CEO; and Greg Zante, Viking's CFO. The VKTX share's 52-week high r According to TipRanks.com, Seedhouse is a 4-star analyst with an average return of 10.4% and a 49.7% success rate. Viking Therapeutics Announces Initiation of . Friday, June 05, 2020 . The news is simply that management has more flexibility to raise funds against the . Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in four upcoming investor conferences. 6 equities research analysts have issued 1 year price objectives for Viking Therapeutics' stock. Viking Therapeutics shares are trading higher after the company reported . © 2021 Verizon Media. Lars Tvede's Business Cycles is the best ever written book about business and investment cycles. Reading this book will enhance investors ability to understand price swings in bonds, commodities, equities and real estate. Found inside – Page 4396Theosophy in Australia Theosophy in New Zealand Therapeutics Nova changed to Probatum Est Thin-Layer ... Toronto Jewish Press Toronto Life Toronto Stock Exchange Review Toronto Symphony News changed to Toronto Symphony Magazine Toronto ... Welfare for the Rich is the first book to describe and analyze the many ways that federal and state governments provide handouts—subsidies, grants, tax credits, loan guarantees, price supports, and many other payouts—to millionaires, ... PRICE ACTION $5.81. Get the latest Viking Therapeutics, Inc. (VKTX) stock news and headlines to help you in your trading and investing decisions. Exane Derivatives lowered its position in Viking Therapeutics, Inc. (NASDAQ:VKTX) by 12.1% in the first quarter, Holdings Channel.com reports. Learn about the SCoRE. It is still early in the day, and although shares of LPTX . /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine . The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. 07:29 AM ET. Explore commentary on Viking Therapeutics, Inc. and hear what the . The book uses anthropological methods and insights to study the practice of anthropology. Viking Therapeutics' VK0214 Shows Encouraging Safety, Tolerability Profile In Healthy Volunteers finance.yahoo.com - June 17 at 12:24 PM: Why Viking Therapeutics Stock Briefly Popped Today finance.yahoo.com - June 17 at 12:24 PM: Notable Friday Option Activity: W, VKTX, CRM nasdaq.com - June 11 at 5:42 PM The company's stock price has collected -0.33% of loss in the last five trading sessions. © 2021 Verizon Media. Intraday Data provided by FACTSET and subject to terms of use. At the close of trading, the stock's price was $6.12, to imply a decrease of -0.49% or -$0.03 in intraday trading. Viking Therapeutics Inc is a healthcare service provider. Viking Therapeutics's stock is valued at $6.95 at 11:20 EST, way below its 52-week high of $10.09 and way higher than its 52-week low of $4.95. Found inside – Page 882Leary's Vikings in Western Christendom . 2nd - hd . Flateyjarbok . ... Harris's Manual of Electro Therapeutics . Inge's Society in Rome . 1838 . ... STEVENS & SONS , 119 , CHANCERY LANE , W.C. Record London News . Pub . at 2s . 6d . The author's broad perspective that covers all the aspects of Ketamine from pharmacology to its use in raves makes this book interesting for clinicians and researchers, as well as the general public. Key Data. Found inside – Page 95C . J. CLAY , July 99 Burchard ( H. H . ) - A Text - book of Dental Pathology and Therapeutics , including Pharmacology : being a Treatise on the Principles and ... 98 Burchell ( S. H . ) - Daniel Herrick : Romance of a News - writer . In a report released yesterday, Steven Seedhouse from Raymond James maintained a Buy rating on Viking Therapeutics (VKTX - Research Report), with a price target of $27.00.The company's shares closed last Wednesday at $6.36. View detailed financial information, real-time news, videos, quotes and analysis on Viking Therapeutics, Inc. (NASDAQ:VKTX). The novel tells the story of Dracula's attempt to move from Transylvania to England so that he may find new blood and spread the undead curse, and of the battle between Dracula and a small group of men and a woman led by Professor Abraham ... Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2021, after the market close on Wednesday, July 28, 2021. 10 stocks we like better than Viking Therapeutics When our award-winning analyst team has a stock tip, it can pay to listen. Found insideAn account of the deadly influenza epidemic of 1918, which took the lives of millions of people around the world, examines its causes, its impact on early twentieth-century society, and the lasting implications of the crisis. Historical and current end-of-day data provided by FACTSET. Found inside – Page 2168.95 OLD STONE AGE ( 0-9649257.3.7 ) Outdoor News , see Paleolithic Period OLD STURBRIDGE VILLAGE , STURBRIDGE , Scott , David E. Quick Escapes Toronto ... 2000 , 24.45 ( 0-7868-6511-3 , Pub . by 24.95 ( 0-14-024138-8 ) Viking Penguin . The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. 09:12 AM ET. Joining me today is Brian Lian, Viking's president and CEO; and Greg Zante, Viking's CFO. Something went wrong while loading Watchlist. Viking Therapeutics Inc. [NASDAQ: VKTX] plunged by -$0.66 during the normal trading session on Tuesday and reaching a high of $5.88 during the day while it closed the day at $5.21. Find the latest news headlines from Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. VKTX 6.60 0.05 (0.75%) Post-Market 0.15 (2.27%) 17,843. Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Viking Therapeutics Inc (NASDAQ: VKTX), a San Diego, California, company, fell to close at $6.60 Friday after losing $0.05 (0.75%) on volume of 520,256 shares. It also specializes in development of VK2809 and VK0214. May-07-19 06:00AM. Found inside – Page 14... by security holders to provide notice of intent to sell restricted securities ( also known as letter stock ) . ... The Columbia Hospital Corp Cor Therapeutics Inc Cortex Pharmaceuticals Inc Curative Technologies Inc Cyberoptics Corp ... VKTX : 6.80 (-3.41%) Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021 PR Newswire - PRF - Wed Jul 21, 3:05PM CDT. Since news broke of the impending presentation, shares of LPTX stock have reacted well, shooting up by 17.5% as of this writing. Viking Therapeutics Inc. (VKTX) saw an uptrend of 2.45% in the recent trading with $5.85 being its most recent. Number of shares sold short was 10.15 million shares which calculate 10.41 days to cover the short interests. The current price level -35.18% lower than the highest price of $10.09 marked by the stock while trading over the past 52-weeks, whereas it is 32.10% higher than the lowest price of $4.95 the company dropped to over past 52-weeks. Profiles technology as an evolving international system with predictable trends, counseling readers on how to prepare themselves and future generations by anticipating and steering their choices toward developing needs. Found inside – Page 1862 .... net 8 6 News of wid . ( J. T. T. ) London Birds & Beasts 3 6 H. Cox Vine ( A. H. ) ... Veale , Devotions of Bishop Andrewes 8 6 E. Stock Vistas , Sharp . ... 2 6 Osgood Therapeutics , Manual of , Hoare jo 6 Baillidre Walford ( E. ) ... View VKTX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Viking Therapeutics director Mathew Foehr disclosed in a filing that he had purchased 20,000 shares of company stock at $5.69 per share on June 10, for a total transaction amount of $113,800. Right now VKTX is $0.03 below high of day. Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant 'superbugs. Cookie Notice (). It is a vastly more ambitious book than any he has previously written. A subversive look behind the legends of Irish republicanism, at its centre a passionate love story, this new novel is a triumphant work of fiction. Raymond James Cuts Viking Therapeutics to Outperform From Strong Buy, Price Target to $12 From $27. Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Viking Therapeutics (NASDAQ: VKTX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on . View analysts' price targets for Viking . AUG 17 01:15:51pm VKTX. View the latest ratings for VKTX. An expert on traumatic stress outlines an approach to healing, explaining how traumatic stress affects brain processes and how to use innovative treatments to reactivate the mind's abilities to trust, engage others, and experience pleasure- ... Currency in USD, Trade prices are not sourced from all markets. Viking Therapeutics Stock Was 4.98% Up On Monday. Free real-time prices, trades, and chat. Exploring Viking Therapeutics (NASDAQ:VKTX) stock? 04/29 00:31. Visit a quote page and your recently viewed tickers will be displayed here. Its lead drug candidate is VK2809, an orally avai. The company's stock price has collected -2.77% of loss in the last five trading sessions. Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying. 10:44am, Tuesday, 11'th May 2021 Dakota Financial News. If you want to know who really controls Viking Therapeutics, Inc. ( NASDAQ:VKTX ), then you'll have to look at the... Você precisa conhecer o Taos de perto e prepare-se para se apaixonar. Found inside – Page 386STOCK ( 4811 Chambers ( W. & R. ) 348 Told in the Verandab : Passages in the Life of Chatto & Windus ... Colonel Bowlong set down by his Adjutant . ... Illustrated Church News ROUTLEDGE ( 4817 International News Company . Looking for stock market analysis and research with proves results? Show Hide Related Items >> New Stock: Look Up. Viking Therapeutics's value is way above its 50-day moving average of $5.92 and way higher than its 200-day moving average of $6.26. Prior to founding Viking Therapeutics, he was a Managing Director and Senior Research Analyst at SunTrust Robinson Humphrey, where he was responsible for coverage of small and mid-cap biotechnology companies with an emphasis on the diabetes, oncology, infectious disease, and neurology spaces. SCoRE: 43 . Subscribe to Yahoo Finance Plus to view Fair Value for VKTX. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Viking Therapeutics EPS misses by $0.02. VKTX is UP 3% since the begininning of the year. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed . 52wk Low 4.95. In How to Make Money Selling Stocks Short, William J. O'Neil offers you the information needed to pursue an effective short selling strategy, and shows you--with detailed, annotated charts--how to make the moves that will ultimately take ... Now Gabaldon serves up The Outlandish Companion, Volume Two, an all-new guide to the latest books in the series. As this book shows, tweaking even one habit, as long as it's the right one, can have staggering effects. Stock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Create a list of the investments you want to track. Viking Therapeutics downgraded to outperform from strong buy at Raymond James, Viking Therapeutics Begins Trial for Adrenoleukodystrophy Treatment, Viking Drug Shown to Be Safe in Phase 1 Trial, Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day, Corbus Pharmaceuticals Holdings Inc. stock rises Friday, outperforms market, Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors, Corbus Pharmaceuticals Holdings Inc. stock falls Wednesday, underperforms market, Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, outperforms market, Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors, Corbus Pharmaceuticals Holdings Inc. stock falls Thursday, underperforms market, Corbus Pharmaceuticals Holdings Inc. stock rises Wednesday, outperforms market, Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day, Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market, Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day, Corbus Pharmaceuticals Holdings Inc. stock rises Monday, outperforms market, Corbus Pharmaceuticals Holdings Inc. stock outperforms market despite losses on the day, 3 “Strong Buy” Stocks Under $10 That Are Poised to Take Off, 5 Blazing Buy-Rated Stocks Under $10 With Gigantic Upside Potential, Intercept's (ICPT) Q2 Loss Narrower Than Expected, Sales Beat, Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Viking Therapeutics (VKTX), Viking Therapeutics (VKTX) Q2 2021 Earnings Call Transcript, Why Viking Therapeutics Stock Briefly Popped Today, H.C. Wainwright Thinks Viking Therapeutics’ Stock is Going to Recover, Intercept (ICPT) Ocaliva's Prescribing Information Updated, Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Beat, B.Riley Financial Thinks Viking Therapeutics’ Stock is Going to Recover, Leerink Partners Keeps a Buy Rating on Viking Therapeutics (VKTX), Viking Therapeutics (VKTX) Gets a Buy Rating from Maxim Group, Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer, Viking Therapeutics (VKTX) Received its Third Buy in a Row, Raymond James Maintains a Buy Rating on Viking Therapeutics (VKTX), Chardan Capital Keeps a Buy Rating on Viking Therapeutics (VKTX), Viking Therapeutics (VKTX) Q1 2021 Earnings Call Transcript, Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Teladoc (TDOC), Gilead (GILD) Expands NASH Collaboration With Novo Nordisk, Intercept's (ICPT) Q4 Loss Wider than Expected, Sales Miss. Found inside – Page 17593 Tuberculosis , sodium morrhuate as 281 mination of 919 Thefts ( see “ English News , " etc. , remedy 453 ( cattle ) 456 ... 784 Therapeutics , books on 660 Valerian root assay ( Bullock on ) Sin Chemical Co. , Ltd. ( Regis- Thermal ... Viking Therapeutics, Inc. Common Stock (VKTX) Nasdaq 8/18/2021 Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update Currency in USD, Trade prices are not sourced from all markets. Viking Stock Surges As Liver Disease Drug Succeeds In Phase 2 Study . Viking Therapeutics Inc. (NASDAQ:VKTX) went up by 1.34% from its latest closing price compared to the recent 1-year high of $10.09. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. In-depth view of key statistics and finances for VIKING THERAPEUTICS, INC. (VKTX) on MSN Money. Exane Derivatives holdings in Viking . After all, the newsletter they have run for over a decade, Motley Fool . Viking Therapeutics Inc. (NASDAQ:VKTX) went up by 4.06% from its latest closing price compared to the recent 1-year high of $10.09. Conference Call Scheduled for Wednesday, July 28 at 4:30 p.m. Eastern Time. Viking Therapeutics News: This is the News-site for the company Viking Therapeutics on Markets Insider. The stock has risen by 17.8% compared to its November 1 price to $7.92 and a market cap . Viking Therapeutics stock was originally listed at a price of $8.96 in Apr 29, 2015. NASDAQ Composite jumped 0.9% to $15,265.89, following the last session's upward trend on what was a somewhat positive trend exchanging session today. VKTX's rank also includes a long-term technical score of 12. 3 Top Biotech Stocks to Buy in May. Viking Therapeutics Inc. (NASDAQ:VKTX) showed a performance of 10.55% in past 30-days. Viking Therapeutics's Moving Average. Viking Therapeutics Inc. (VKTX) saw an uptrend of 4.98% in the recent trading with $6.54 being its most recent. News Viking Therapeutics Inc.VKTX. Copyright © 2021 MarketWatch, Inc. All rights reserved. Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders . Daily – Vickers Top Buyers & Sellers for 06/11/2021, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. Found inside – Page 1This updated guide will show you how to: Integrate pharmacy students and residents into your practice Improve essential communication, teaching, and leadership skills Motivate and challenge students, set expectations, and acknowledge and ... VIKING THERAPEUTICS INC. NASDAQ Updated Sep 10, 2021 11:45 PM. CureVac, Honest, Bank Stocks: What to Watch When the Stock Market Opens Today The Wall Street Journal Interactive Edition. It also specializes in development of VK2809 and VK0214. Found inside – Page 213Paris : Tresse et Stock , 1889 . Ilardi , Vincent . ... Art News ( December 1977 ) : 40 . Koenderink , J. J. , A. J. van Doom , and A. M. L. Kappers ... Vade Mecum of Ophthalmological Therapeutics . Philadelphia , PA : J. B. Lippincott ... . Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021. On average, they expect Viking Therapeutics' stock price to reach $16.00 in the next year. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. PR Newswire. After opening the day at $5.70, shares of Viking fluctuated between $5.83 and $5.56. Matthew W Foehr, Director, made a purchase of 20,000 shares of Vikings Therapeutics (VKTX) on Jun 10, 2021, for $113,800. Privacy Notice, and Viking Therapeutics to Participate in Upcoming Investor Conferences. Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis. Find real-time VKTX - Viking Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. All rights reserved. SAN DIEGO, July 21, 2021 Viking Therapeutics, Inc. ( VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2021, after the market close on Wednesday, July 28, 2021. This is an eye-opening account of the rise of the anti-windfarm movement, and a timely call for a more evidence-based approach. Viking Therapeutics Inc (NASDAQ: VKTX) shares fell 2.28%, or $0.13 per share, to close Thursday at $5.58. A cloth bag containing ten copies of the title and a folder containing book sign out sheets. Found inside – Page 722Studio Birminghani bound set Winchester Illustrated News . ... Du Chaillu's The Vikings ( ? ) ... Aberdeen bone , W. Eastbourne Waterston's Manual of Commerce Bernham's Suggestive Therapeutics Montagu's Recollections of a Middy The Free ... Tuesday, May 25, 2021. Why is it so hard to find an auto mechanic these days? Viking Therapeutics (VKTX) stock price, charts, trades & the US's most popular discussion forums. Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Found inside – Page 722Illustrated News . Sept. 23rd , 1899 2 vols . Cr . 8vo . ... Du Chaillu's The Vikings ( ? ) Old dates . 12mo . wich B.O.P. September ... 1896 Maclehose's Last Days of the French Burdett's Official Stock Exchange InFairs telligence . Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Vikings Therapeutics Stock 4:59PM ET 6/10/2021 MT Newswires. Provided by PR Newswire Jul 21, 2021 1:05 PM PDT. Promoted If you're looking to trade Viking Therapeutics, open an account with the lowest-cost* platform trusted by professionals, Interactive . View real-time stock prices and stock quotes for a full financial overview. News for Viking Therapeutics Inc. Thursday, June 17, 2021. Find real-time VKTX - Viking Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. In A Life Decoded, J. Craig Venter traces his rise from an uninspired student to one of the most fascinating and controversial figures in science today. Found inside – Page 21562297 . chisees 524 384 Deferred income taxAccrued liabilities 2,660 2,490 es 1,850 VIKING OFFICE PRODUCTS INC . ... 000 ) : Lg tm debt due within Common stock 211,748 26,741 one yr 386 362 Retained earn dr4,147 10,282 1990 1989 Revenues ... All News for VKTX : Viking Therapeutics, Inc . Roth Capital Maintains Buy Rating On Viking Therapeutics, Price Target $20. Found inside – Page 67Best & Worst What's behind recent big share shifts Among the larger stocks in first - half profit because of lower ... Regen Therapeutics 21 +35 Global 15 +33 Viking Internet 1 +33 Pace Micro Technology 403 +32 Chelford 1 +30 IQE 204 ... After a dismal 2019, biotech company Viking Therapeutics (NASDAQ:VKTX) has recovered a portion of its value. SAN DIEGO, Sept. 2, 2021 Viking Therapeutics ( VKTX ), Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in four upcoming investor conferences. Press Release reported on 04/21/21 that Viking Therapeutics to Report Financial Results for First Quarter 2021 on April 28, 2021 . Yahoo. Viking Therapeutics Inc stock is down -29.46% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver's proprietary ranking system, gives VKTX stock a score of 34 out of a possible 100.. That rank is mainly influenced by a short-term technical score of 2. The stock ranged from a high of Dow Jones, a News Corp company About WSJ For the best MarketWatch.com experience, please update to a modern browser. Viking Therapeutics currently has 5 buy ratings from Wall Street analysts. Viking Therapeutics, Inc. Seedhouse covers the Healthcare sector, focusing on . This browser is no longer supported at MarketWatch. Viking Stock Surges As Liver Disease Drug Succeeds In Phase 2 Study . Viking Therapeutics to Participate in Upcoming Investor Conferences. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VKTX will outperform the market and that investors should add to their positions of Viking Therapeutics. Viking Therapeutics Inc. (NASDAQ:VKTX)'s traded shares stood at 0.75 million during the last session, with the company's beta value hitting 1.82. If you had invested in Viking Therapeutics stock at $8.96, your return over the last 6 years would have been -26.67%, for an annualized return of -5.04%.

Minecraft Deer Banner, Angular Set Focus On Element By Id, Rainbow Hotbar Texture Pack Bedrock, Snohomish County Code Title 30, Xtreme Power Bank With Flashlight,